Technical Analysis for VRNA - Verona Pharma plc

Grade Last Price % Change Price Change
F 15.53 -0.77% -0.12
VRNA closed down 0.77 percent on Monday, March 18, 2024, on 43 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -0.77%
Narrow Range Bar Range Contraction -0.77%
Stochastic Reached Oversold Weakness -0.77%
Inside Day Range Contraction -0.77%
Oversold Stochastic Weakness -0.77%
Evening Star Bearish -0.06%
Lower Bollinger Band Walk Weakness -0.06%
BB Squeeze Ended Range Expansion -0.06%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
Outside Day about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
Down 1% about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders

Is VRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.81
52 Week Low 11.83
Average Volume 502,305
200-Day Moving Average 17.58
50-Day Moving Average 17.37
20-Day Moving Average 16.75
10-Day Moving Average 16.25
Average True Range 0.86
RSI (14) 39.39
ADX 14.79
+DI 16.08
-DI 29.27
Chandelier Exit (Long, 3 ATRs) 15.91
Chandelier Exit (Short, 3 ATRs) 17.92
Upper Bollinger Bands 18.19
Lower Bollinger Band 15.30
Percent B (%b) 0.08
BandWidth 17.21
MACD Line -0.42
MACD Signal Line -0.28
MACD Histogram -0.1437
Fundamentals Value
Market Cap 1.24 Billion
Num Shares 79.9 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -27.73
Price-to-Sales 2981.17
Price-to-Book 5.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.36
Resistance 3 (R3) 16.39 16.14 16.22
Resistance 2 (R2) 16.14 15.93 16.13 16.17
Resistance 1 (R1) 15.84 15.80 15.72 15.81 16.13
Pivot Point 15.59 15.59 15.53 15.58 15.59
Support 1 (S1) 15.29 15.38 15.17 15.26 14.93
Support 2 (S2) 15.04 15.25 15.03 14.89
Support 3 (S3) 14.74 15.04 14.84
Support 4 (S4) 14.71